Benzinga··Vandana SinghEdwards Lifesciences Crushes Q1 Earnings on Heart Valve Device Boom
Edwards Lifesciences beats Q1 earnings expectations, reporting 78-cent EPS and $1.65B revenue while raising 2026 guidance on strong heart valve device growth.
EWguidance raiseQ1 earnings